| Identifier |
19960215_nanos_ms-onsympos_07 |
| Title |
New Treatments for Multiple Sclerosis |
| Creator |
Barry G. W. Amason |
| Affiliation |
Chicago, IL |
| Subject |
Multiple Sclerosis; Treatments; Betaseron; Avonex; Copolymer 1; Oral Myelin; Methotrexate; Cladribine; Imuran; Retinoic Acid |
| Description |
Betaseron (IFN-1b) is approved for treatment of relapsing remitting multiple sclerosis (MS). The agent lessons overall MS attack frequency by 35 percent, major attack frequency by 50 percent, and markedly lessons accumlating disease burden and disease activity as assessed by MRI scanning. |
| Date |
1996-02-15 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
1996 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS 1996: Multiple Sclerosis Symposium |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 1996. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6n333j0 |
| Setname |
ehsl_novel_nam |
| ID |
182586 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6n333j0 |
